McKesson Corporation
Prix: 784.05Entreprise et modèle économique
McKesson Corporation is a leading healthcare services and information technology company. It primarily operates in the distribution of pharmaceuticals and provides healthcare management solutions. Major business segments include pharmaceutical distribution, medical-surgical distribution, and healthcare technology. The company's main revenue sources are from the sale of prescription drugs, medical supplies, and related services to healthcare providers, pharmacies, and hospitals.
Profil d’investissement
The investment profile of McKesson Corporation is more aligned with value investors, given its stable revenue growth and modest dividend yield. The stock may appeal to those seeking a balanced approach, as it offers potential for capital appreciation alongside income generation. However, the higher risk factors suggest caution for investors.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 38.64 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- -9.3% ↓
- Surprise BPA
- 1.9% conforme
- Volatilité 20 j
- 1.4% stable
- Rendement du dividende
- 0.4% faible dernière date ex-dividende: 2026-06-01
Suivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-06-09 02:45 | Acheter | Vendre | Weak fundamentals and negative momentum raise concerns. |
| 2026-06-05 02:42 | Conserver | Acheter | Mixed performance; cautious outlook amid market pressures. |
| 2026-06-01 02:44 | Vendre | Conserver | Weak momentum and high risk overshadow potential upside. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-05-08 14:52 | UBS | Objectif relevé | 1000 → 1050 | 744.46 |
| 2026-05-08 12:53 | Deutsche Bank | Objectif abaissé | 973 → 875 | 763.9 |
| 2026-03-05 15:28 | Raymond James | Mettre à jour | — → 970 | 930.31 |
Rien pour le moment